ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
CNBX Pharmaceuticals Inc (QB)

CNBX Pharmaceuticals Inc (QB) (CNBX)

0.0071
-0.0003
(-4.05%)
Closed July 13 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0071
Bid
0.0057
Ask
0.0078
Volume
134,393
0.0057 Day's Range 0.00738
0.005 52 Week Range 0.0487
Market Cap
Previous Close
0.0074
Open
0.0072
Last Trade
50000
@
0.0071
Last Trade Time
Financial Volume
$ 915
VWAP
0.006812
Average Volume (3m)
248,234
Shares Outstanding
31,111,352
Dividend Yield
-
PE Ratio
-0.08
Earnings Per Share (EPS)
-0.12
Revenue
410k
Net Profit
-3.71M

About CNBX Pharmaceuticals Inc (QB)

CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the experti... CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Las Vegas, Nevada, USA
Founded
1970
CNBX Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker CNBX. The last closing price for CNBX Pharmaceuticals (QB) was $0.01. Over the last year, CNBX Pharmaceuticals (QB) shares have traded in a share price range of $ 0.005 to $ 0.0487.

CNBX Pharmaceuticals (QB) currently has 31,111,352 shares outstanding. The market capitalization of CNBX Pharmaceuticals (QB) is $230,224 . CNBX Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of -0.08.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-5.333333333330.00750.00750.0057345540.00697588CS
4-0.0009-11.250.0080.00940.0051195150.00775125CS
12-0.0044-38.26086956520.01150.01480.0052482340.01000914CS
26-0.01075-60.22408963590.017850.01830.0052440770.011413CS
52-0.0049-40.83333333330.0120.04870.0053584620.0189461CS
156-0.1809-96.22340425530.1885.50.0052587760.04429991CS
260-0.3329-97.91176470590.345.50.0052690550.1532479CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

CNBX Discussion

View Posts
Bionic Man Bionic Man 1 month ago
I agree, thank you!
👍️0
Gnarlyman Gnarlyman 1 month ago
I said a lot about what I thought last fall. When they replaced the original Dr. for the new lady, I had my doubts. GLTU B-man

It’s OTC so no one ever really knows.
👍️0
Bionic Man Bionic Man 1 month ago
I honestly think the only volume here anymore is MM’s trading between each other. We need updates soon, or this is tanking to trips eventually.
👍️0
Bionic Man Bionic Man 1 month ago
If they don’t have the same rented space, and DR’s or a DR. left, it’s pretty telling that they probably don’t have much left. Not sure what or if they can be saved. Lack of news isn’t what I wanted.
👍️0
Gnarlyman Gnarlyman 1 month ago
What’s interesting is 3I hasn’t really added shares for a while and it is still only 30M. We were betting on the OS raises in August or so and that’s when it first hit 28M, 2 mil adds in 8 months is pretty low.

Gonna see how low it goes since the .01 break happened and whatever was propping it up before appears to be gone.
👍️0
Bionic Man Bionic Man 1 month ago
Looks like MM’s are just manipulating the stock. Nothing new here, and this will probably go to .005 soon.
👍️0
backtoreality backtoreality 1 month ago
I held in there as ling as I could. I kept a few shares in case they release something good I'll be able to jump back on but definitely issues here.
👍️0
Bionic Man Bionic Man 2 months ago
Wow, this company is in huge trouble.
👍️0
jwakstock jwakstock 2 months ago
I agree..... may be headed to triple zeros now. I just sold. GLTU
👍️0
Bionic Man Bionic Man 2 months ago
Not looking good.
👍️0
Gnarlyman Gnarlyman 2 months ago
Down below .01, wondering how long now. Will it be below by days end?
👍️0
Gnarlyman Gnarlyman 2 months ago
Popped on my alerts, I’ve been watching it for a while. Curious if it keeps going or if someone saves it.
👍️0
Bionic Man Bionic Man 2 months ago
Looks like this may not hold .01 anymore.
👍️0
backtoreality backtoreality 2 months ago
A million shares traded at eod??
👍️0
backtoreality backtoreality 2 months ago
Thanks Man, but I f in sold too many shares after that filing because of what happened at abqq.

I should of waited to get a feel for the market reaction and I know you should never buy or sell a huge lot at once.

I noticed right before news hit or the same time there was a big buy with Cbdd and Ilst. That's a sharp investor.
👍️0
Gnarlyman Gnarlyman 2 months ago
Well GLTU, I’m not expecting much, the whole cannabis sector moved today on that huge news. Not sure these guys are in a position to capitalize on anything other than hype since they’ve never even started Pre-IND meetings with the FDA.

FYI, I’m not holding the stock, just watching because of the curious ability for it to keep the QB required price.
👍️0
Bionic Man Bionic Man 2 months ago
I am also surprised, but great that it’s heading north again. I just don’t trust the market makers with their shares. If it gets past .025I’ll be looking at buying more
👍️0
Gnarlyman Gnarlyman 2 months ago
Supposedly had a cannabis based cancer drug called RCC-133. Now they have 2 employees according to the last filing. Israeli based company with an office in at a law firm in Bethesda,MD. Still baffles me why it is over .01 but maybe it will get interesting on the new DEA marijuana scheduling if it gets final approval. GLTU BTR.
👍️0
backtoreality backtoreality 2 months ago
Are they involved in Cannabis do you know?
👍️0
backtoreality backtoreality 2 months ago
Low floater for sure! Time for a CEO tweet.
👍️0
surf1944 surf1944 2 months ago
CNBX updated the O/S on the 26th with no change, today positive action in CNBX.

Outstanding Shares
31,111,352
04/26/2024
👍️0
Gnarlyman Gnarlyman 3 months ago
I don’t follow ABQQ, but I usually avoid most stocks run over in China. GLTU
👍️0
backtoreality backtoreality 3 months ago
Thanks for the reply. I thought about your assessment and decided unless that I'd take some of my shares and put it somewhere else that hopefully has better potential. I've been patient long enough with these guys.

The other day ABQQ had a not so great filing and it crashed. But they PRed in March that revs were booming but ended up reporting lame numbers. Can't trust a chinaman I guess.
👍️0
Gnarlyman Gnarlyman 3 months ago
I don’t own any, I just follow this stock because I’m highly curious why it has been propped up above .01.

That’s an OTC oddity I’m interested in watching until it finally falls. If it doesn’t it would confirm to me the directors have a deal with the convertible loan holder to keep it above the .01 threshold to retain their OTCQB rating. I’m treating it as a learning experience, nothing more really.

If and when I think it’s worth buying I would, but that is currently not the case IMO.

GLTU
👍️0
backtoreality backtoreality 3 months ago
If the company is toast why aren't you selling, or any one else for that matter?
👍️0
Gnarlyman Gnarlyman 3 months ago
This company is toast, sorry, they sold the lab according to the filing and only have the 2 officers as employees accumulating salary debt.

All the drugs they pimp haven’t changed. And they still haven’t completed the Phase 1 FDA Pre-IND submission. The can’t afford it.

From filing:

We are currently identifying potential contract research organizations and clinical trial centers to conduct the Phase I/II(a) human proof of concept study, which is estimated to cost $6,500,000. As of the date of this filing, however, the Company does not have sufficient funds to complete the Phase I/II(a) study.

Subject to the results from our Phase I trials, we plan to submit an IND to the FDA for RCC-33 with the clinical protocol for a Phase II double-blind placebo controlled clinical trial evaluating RCC-33 in patients with CRC at various dosing levels versus placebo. The outcomes from the planned Phase II human proof of concept trial will inform our decision regarding further steps in the clinical development of RCC-33.
👍️0
backtoreality backtoreality 3 months ago
Yeah baby I'm locked and loaded!

I like Fireworks. Thank you!
👍️0
jwakstock jwakstock 3 months ago
10-Q out. Very impressive 10-Q as the company has a lot of drugs on the pipeline to start Phase I/II this year (there is one underway in the 1st qtr of 2024). Plus they made a profit in this qtr compared to a big loss in 2023. 2024 is the year for this company. No changes in outstanding shares. Must be the only company with a tiny 31M float and lots of upside potential. Fireworks are about to begin. CNBX
http://archive.fast-edgar.com/20240416/A322M22CZ22HW9Z2222H2ZYZ3LPS8ZK2S262
👍️0
backtoreality backtoreality 3 months ago
It's amazing the share price remains north of a penny. I think once maybe twice it went south for a minute.

I'm not a fan of penny flippers, that's why otc stocks don't have good runs anymore in my opinion.
👍️0
EOT EOT 3 months ago
Someone has been flipping it successfully from .11 then dumping at .014 continuously lol.

The company or website hasn’t been updated in years-since 2022. SMH
👍️0
backtoreality backtoreality 3 months ago
That's because so many shares have been bought in this range, one tweet and Wow!
👍️0
gypsy11 gypsy11 3 months ago
This stock will move quickly once the company makes some significant progress. We can only hope that is sometime soon as we haven’t heard much lately.
👍️0
surf1944 surf1944 3 months ago
CNBX updated the O/S on Friday the 5th with no change, then today there is positive action in CNBX.

Outstanding Shares
31,111,352
04/05/2024
👍️0
backtoreality backtoreality 3 months ago
Thanks for posting. Got to get that monkey off our back. Then maybe the ceo will make a showing with healthy news.

If so surely we'll pass a dime/shr.
👍️0
surf1944 surf1944 3 months ago
There has been no increase the O/S count for months, but I believe that may change soon, that was likely the note holder selling yesterday.

Market Cap Market Cap
342,225
04/04/2024
Authorized Shares
900,000,000
03/28/2024
Outstanding Shares
31,111,352
03/28/2024
Restricted
733,640
03/28/2024
Unrestricted
30,377,712
03/28/2024
Held at DTC
30,367,900
03/28/2024
Float
4,196,841
05/26/2023
👍️0
Bionic Man Bionic Man 3 months ago
Still holding 1 million shares. Hoping it goes back to .05-.10 with good news.
👍️0
GoResearch GoResearch 3 months ago
Still holding 320K shares.
👍️0
surf1944 surf1944 3 months ago
Holding 500K shares, just waiting for some news, the O/S count has not increased for a few months which is a good sign, this is the only OTCBB stock that I own.
👍️0
hotdawg hotdawg 4 months ago
Still holding and waiting for some movement. may pick up a few more.
👍️0
backtoreality backtoreality 4 months ago
No posts in a month. Anyone still holding?
👍️0
snackcrackpop snackcrackpop 4 months ago
Very little volume here! Is this a medical stock or what exactly are they doing?
👍️0
mrinvestor08 mrinvestor08 5 months ago
If they hire a new doctor we see 0.05 again. That will be a sign that research team is up and running again.
👍️0
EOT EOT 5 months ago
“We had this discussion before, 3i cannot hold more than 9.99% due to the blocker. “

That’s what I said.
👍️0
Gnarlyman Gnarlyman 5 months ago
We had this discussion before, 3i cannot hold more than 9.99% due to the blocker.
They only hold and file a 13 when they create enough shares in the O/S through their LOAN conversion dilution to the float.

So, 3i converts some to the open market then keep some to maintain their 9.99%. The rest covert to whoever will buy them over .01 for the most part. Usually its when the price organically starts to rise because they manufacture the subtle quiet period between cycles.

Either way, unless CNBX starts making money and plans to release info, the debt holder will maintain this YO-YO cycle, so just play it when able.

Based on remaining debt, 3i will convert probably 150-300M, just a guess. Could be less or more.

At least 3i hasn’t asked for another promissory note for failure to pay.
👍️0
EOT EOT 5 months ago
SC 13G/A ….3i Management LLC, are the company’s financier’s.

If you look at the original SC 13G from 03/06/2023 they had less shares, but always less than 10%. Today’s amendment looks like now they have more shares to sell?
Doesn’t mean they have to sell them, but why would they get them? I imagine if the company started making moves they would hold and let the price rise? It’s a different kind of dilutive financing, but actually pretty good if the company does well??
That’s what I think??? IMO
Everyone should read it for themselves…..
👍️ 1
surf1944 surf1944 5 months ago
https://www.otcmarkets.com/otcapi/company/financial-report/392190/content

The company holding the shares is the note company.
👍️0
hotdawg hotdawg 5 months ago
If i read this correctly they have almost 30% of the shares available.
👍️0
surf1944 surf1944 5 months ago
https://ih.advfn.com/stock-market/USOTC/cnbx-pharmaceuticals-qb-CNBX/stock-news/93269065/form-sc-13g-a-statement-of-acquisition-of-benefi

Interesting filing this could have been some of the recent volume in the stock.
👍️ 1
GoResearch GoResearch 5 months ago
Not me, yet. 320K shares here. Looking to add more next week.
👍️0
surf1944 surf1944 5 months ago
The good news with that volume, there was no increase in O/S for CNBX.
👍️0

Your Recent History

Delayed Upgrade Clock